InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,399.22
(
-0.51%
)
US TECH 100
18,532.00
(
1.10%
)
Dow Jones
39,935.07
(
0.20%
)
Brent Oil
81.15
(
-0.48%
)
Bitcoin
67,322.50
(
2.33%
)
Post# of 216
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TREND1

Send PM Follow Ignore
Followers 416
Posts 52354
Boards Moderated 13
Alias Born 12/16/2001

TREND1

Member Level

Re: None

Tuesday, 10/10/2017 1:27:06 PM

Tuesday, October 10, 2017 1:27:06 PM

Post# of 216
10/10 MannKind Is A Trade Not An Investment;

•MannKind is moving up, but we still don’t consider it a strong investment.

•Imfinzi MAA was accepted for Stage III lung cancer.

•Onconova's rigosertib is progressing well.


https://seekingalpha.com/article/4112686-daily-pharma-scoop-mannkind-trade-investment-astrazenecas-imfinzi?auth_param=1vat:1ctpqf0:fac82bba8ca11e5c55095f60991c4816&uprof=51

TRADING 01 LIST https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133836402

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up